Reality or Fantasy?
Take a close look at these words spoken by Medtronic CEO Geoffrey Martha yesterday during the company’s earnings call-
“Look, we have not blinked when it comes to diabetes, and we're shifting to offense as we continue to invest heavily in assembling our ecosystem of durable pumps, smart pens, patch pumps, sensors, algorithms and customer service with multiple programs under development. Having this ecosystem is really important because we believe the market will move from CGM first to automated insulin delivery, and we are well positioned for that trend. We look forward to updating all of you on . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.